Hayakawa et al (2003) showed that endogenous ROS produced through Rac/NADPH oxidase do not mediate NF-κB signalling. It is thus plausible that the inhibition of NF-κB activity was independent of the ROS induced by BD treatment. This evidence concerns the gene FMO5 and Behcet disease.